GenVec's CEO Discusses Q2 2012 Results - Earnings Call Transcript

GenVec, Inc. (GNVC)

Q2 2012 Earnings Conference Call

August 9, 2012 10:00 AM ET


Douglas Swirsky – Senior Vice President & Chief Financial Officer

Cynthia Collins – President & Chief Executive Officer


Joseph Pantginis - Roth Capital Partners

Julie Bickel - Boenning & Scattergood

Peter Stackeof [ph] - Private Investor



Good morning ladies and gentlemen, welcome to GenVec’s 2012 second quarter earnings conference call. My name is Bonney, and I will be your conference facilitator today. At this time, all participants are in a listen-only mode. After GenVec’s management concludes their remarks, there will be a question-and-answer period. (Operator Instructions)

We would like to remind everyone that this call is being recorded today, Thursday, August 9 th, 2012. If you do not wish to continue your participation, you may disconnect at any time. I will now turn the call over to Mr. Douglas Swirsky, GenVec’s Senior Vice President and Chief Financial Officer.

Douglas Swirsky

Thank you for participating in this call. Joining me this morning is Ms. Cindy Collins, GenVec’s President and CEO. During this call, we will make forward-looking statements within the meaning of the Private Securities Litigation Reform Act involving risks and uncertainties and our actual results may differ materially from our expectations.

For a complete statement of these risks, please review statements made in our SEC filings and this morning’s press release. Today, you will hear Cindy review GenVec’s strategy and discuss the progress we are making. I will then provide you with an overview of GenVec’s second quarter financial results.

If you liked this article you might like

This Small-Cap Rotation Is Unconvincing

7 Stocks Under $10 Spiking Toward Big Gains

5 Stocks Under $10 Set to Soar Higher

5 Stocks Under $10 Set to Soar Higher

A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks

3 Stocks Pushing The Drugs Industry Lower